RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells

      한글로보기

      https://www.riss.kr/link?id=A107379903

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Melanoma-associated antigen C2 (MAGEC2) is an oncogene associated with various types of cancers. However, the biological function of MAGEC2 in circulating tumor cells remains unclear. In this study, we investigated the role of MAGEC2 using ad...

      Purpose: Melanoma-associated antigen C2 (MAGEC2) is an oncogene associated with various types of cancers. However, the biological function of MAGEC2 in circulating tumor cells remains unclear. In this study, we investigated the role of MAGEC2 using adapted suspension cells (ASCs), which were previously developed to study circulating tumor cells (CTCs).
      Methods: Differential gene expression in adherent cells (ADs) and ASCs was examined using RNA-seq analysis. MAGEC2 expression was assessed using reverse transcription quantitative polymerase chain reaction (RT-qPCR), immunoblotting, and ChIP-seq analysis. Depletion of MAGEC2 expression was performed using siRNA. MAGEC2-depleted ADs and ASCs were used to investigate changes in the proliferation rate and cell cycle. Then, the protein levels of signal transducer and activator of transcription 3 (STAT3), phosphorylated STAT3, and downstream of STAT3 were measured using control and MAGEC2-depleted ADs and ASCs. In ASCs, the direct effect of active STAT3 inhibition with Stattic, a STAT3 inhibitor, was assessed in terms of proliferation and apoptosis. Finally, an Annexin V/7-AAD assay was performed to determine the percentage of apoptotic cells in the Stattic-treated cells.
      Results: MAGEC2 was highly expressed in ASCs when compared with ADs. Depletion of MAGEC2 reduced the proliferation rate and viability of ASCs. To elucidate the underlying mechanism, the level of STAT3 was examined owing to its oncogenic properties. Tyrosinephosphorylated active STAT3 was highly expressed in ASCs and decreased in MAGEC2- depleted ASCs. Furthermore, on treating ASCs with Stattic, an active STAT3 inhibitor, the cells were markedly sensitive to intrinsic pathway-mediated apoptosis.
      Conclusions: High MAGEC2 expression may play an important role in the survival of ASCs by maintaining the expression of activated STAT3 to prevent apoptotic cell death.

      더보기

      참고문헌 (Reference)

      1 Levy DE, "What does Stat3 do?" 109 : 1143-1148, 2002

      2 Song X, "The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling" 36 : 1476-1486, 2017

      3 Yu H, "The STATs of cancer--new molecular targets come of age" 4 : 97-105, 2004

      4 Barker PA, "The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease" 67 : 705-712, 2002

      5 Hsieh TC, "The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells" 31 : 1293-1300, 2007

      6 Park JY, "Silent mating-type information regulation 2 homolog 1 overexpression is an important strategy for the survival of adapted suspension tumor cells" 110 : 2773-2782, 2019

      7 Chun J, "Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDAMB-231 breast cancer cells" 32 : 2501-2509, 2018

      8 Devarajan E, "STAT3 as a central regulator of tumor metastases" 9 : 626-633, 2009

      9 Ma JH, "Role of STAT3 signaling pathway in breast cancer" 18 : 33-, 2020

      10 Yu H, "Revisiting STAT3 signalling in cancer : new and unexpected biological functions" 14 : 736-746, 2014

      1 Levy DE, "What does Stat3 do?" 109 : 1143-1148, 2002

      2 Song X, "The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling" 36 : 1476-1486, 2017

      3 Yu H, "The STATs of cancer--new molecular targets come of age" 4 : 97-105, 2004

      4 Barker PA, "The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease" 67 : 705-712, 2002

      5 Hsieh TC, "The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells" 31 : 1293-1300, 2007

      6 Park JY, "Silent mating-type information regulation 2 homolog 1 overexpression is an important strategy for the survival of adapted suspension tumor cells" 110 : 2773-2782, 2019

      7 Chun J, "Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDAMB-231 breast cancer cells" 32 : 2501-2509, 2018

      8 Devarajan E, "STAT3 as a central regulator of tumor metastases" 9 : 626-633, 2009

      9 Ma JH, "Role of STAT3 signaling pathway in breast cancer" 18 : 33-, 2020

      10 Yu H, "Revisiting STAT3 signalling in cancer : new and unexpected biological functions" 14 : 736-746, 2014

      11 Zhao Q, "Pilot study on MAGE-C2 as a potential biomarker for triple-negative breast cancer" 2016 : 2325987-, 2016

      12 Carneiro Leão G, "Occurrence of Campylobacter pylori in patients with gastritis and peptic ulcer" 25 : 23-28, 1988

      13 Nguyen DX, "Metastasis : from dissemination to organ-specific colonization" 9 : 274-284, 2009

      14 Yang F, "MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis" 145 : 23-32, 2014

      15 Doyle JM, "MAGE-RING protein complexes comprise a family of E3ubiquitin ligases" 39 : 963-974, 2010

      16 von Boehmer L, "MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer" 6 : e21366-, 2011

      17 Cameron BJ, "Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells" 5 : 197ra103-, 2013

      18 Agnoletto C, "Heterogeneity in circulating tumor cells: the relevance of the stem-cell subset" 11 : 483-, 2019

      19 Yawata T, "Enhanced expression of cancer testis antigen genes in glioma stem cells" 49 : 532-544, 2010

      20 Park JY, "Development of suspension cell culture model to mimic circulating tumor cells" 9 : 622-640, 2017

      21 Pantel K, "Detection, clinical relevance and specific biological properties of disseminating tumour cells" 8 : 329-340, 2008

      22 Ye Z, "Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies" 20 : 546-551, 2019

      23 Bednarz-Knoll N, "Clinical relevance and biology of circulating tumor cells" 13 : 228-, 2011

      24 Meng S, "Circulating tumor cells in patients with breast cancer dormancy" 10 : 8152-8162, 2004

      25 Simpson AJ, "Cancer/testis antigens, gametogenesis and cancer" 5 : 615-625, 2005

      26 Gordeeva O, "Cancer-testis antigens : unique cancer stem cell biomarkers and targets for cancer therapy" 53 : 75-89, 2018

      27 Lajmi N, "Cancer-testis antigen MAGEC2promotes proliferation and resistance to apoptosis in Multiple Myeloma" 171 : 752-762, 2015

      28 Han S, "C1q/TNF-α-related protein 1(CTRP1)maintains blood pressure under dehydration conditions" 123 : e5-e19, 2018

      29 Castedo M, "Apoptosis regulation in tetraploid cancer cells" 25 : 2584-2595, 2006

      30 Wegenka UM, "Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level" 13 : 276-288, 1993

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-04-06 학술지명변경 외국어명 : Journal of Korean Breast Cancer -> Journal of Breast Cancer KCI등재
      2011-03-23 학술지명변경 외국어명 : Journal of Korean Breast Cancer -> 미등록 KCI등재
      2011-03-04 학술지명변경 한글명 : 한국유방암학회지 -> Journal of Breast Cancer KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2008-01-01 평가 SCIE 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.99 0.19 1.31
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.96 0.77 0.448 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼